peyman etemadfar

yasuj university of medical sciences

[ 1 ] - Comparison of Deferoxamine, Deferiprone and Deferasirox Iron-Chelating Agents in Reducing Serum Ferritin Levels in Patients with Thalassemia Major

Aims: Patients with thalassemia major suffer from iron overload due to excessive cell lysis. Iron-chelating agents are used to preventing the effects of iron overload on the body. Deferoxamine, deferiprone, and deferasirox are the most common iron-chelating agents. The aim of this study was to compare deferoxamine, deferiprone, and deferasirox iron-chelating agents in reducing serum ferritin leve…

Co-Authors